Lymphoma (includes NHL, HL, CNS Lymphoma)
Featured Articles
(PharmaTimes [UK]) Dec 15, 2017 - It is looking likely that a subgroup of patients with mantle cell lymphoma (MCL) will get routine access to Janssen’s Imbruvica on the NHS.
Read Article
(Bloomberg Quint) Dec 14, 2017 - Two months after Gilead Sciences Inc.’s breakthrough treatment was approved in the U.S. to treat a deadly form of blood cancer, only a tiny handful of patients have actually gotten the costly therapy, while others linger on waiting lists.
Read Article
Latest Articles
December 14, 2017
December 13, 2017
December 13, 2017
December 13, 2017
December 13, 2017
December 12, 2017
December 12, 2017
December 12, 2017
View More
News Commentary
Editor Image
05 Oct, 2017 | by Dean Gesme, MD
An excellent editorial this past week in JCO authored by Jim Armitage and Dan...
View Comment
View More
OBR Green
There are no Lymphoma (includes NHL, HL, CNS Lymphoma) OBR Green articles.
OBR Blog
Introduction In an effort to provide you with timely market feedback from the 58th ASH Annual Meeting held in December... Read more
January 06, 2017